Strategic Aim 7: Minimising the risk of poly-pharmacy No Objective Action Key For Outcome for Progress to RAG partners completion patients date/current Rating by: - position 1 To progress polypharmacy issues To progress polypharmacy Medicines Ongoing Improved prescribing Ongoing work in identified in previous cluster issues identified in previous management and mechanisms for practices also network plan cluster network plan team and polypharmacy review supported by the Practice Medicines Management team 2 To ensure appropriate use of the Work with medicines Medicines Ongoing Improved access to Cluster Pharmacist pharmacist and technician management team to deliver better pharmaceutical appointed as well as management resources (cluster and non-cluster and ensure appropriate care other support from team and funded) to reduce risks from training, support and indemnity Health Board Practice polypharmacy and improve other arrangements Medicines Teams aspects of medicines management team management Work ongoing to clarify roles, training requirements and indemnity arrangements 3 To engage in the Prescribing Undertake a range of GPs PMS 16/17 by Improved medicines Discussed at all – Management Scheme (PMS) and prescribing initiatives to Practice 17 management including annual practice PMS+ respiratory schemes improve: Nurses (some Dec polypharmacy prescribing visits respiratory, antibiotic,
Strategic Aim 7: Minimising the risk of poly-pharmacy No Objective Action Key partners For completion by: - Outcome for patients Progress to date/current position RAG Rating 1 To progress polypharmacy issues identified in previous cluster network plan To progress polypharmacy issues identified in previous cluster network plan Medicines management team and Practice Ongoing Improved prescribing and mechanisms for polypharmacy review Ongoing work in practices also supported by the Medicines Management team 2 To ensure appropriate use of the pharmacist and technician resources (cluster and non-cluster funded) to reduce risks from polypharmacy and improve other aspects of medicines management Work with medicines management team to deliver and ensure appropriate training, support and indemnity arrangements Medicines management team and Practice Teams Ongoing Improved access to better pharmaceutical care Cluster Pharmacist appointed as well as other support from Health Board Medicines management team Work ongoing to clarify roles, training requirements and indemnity arrangements 3 To engage in the Prescribing Management Scheme (PMS) and PMS+ respiratory schemes Undertake a range of prescribing initiatives to improve: respiratory, antibiotic, GPs Practice Nurses PMS 16/17 – by 17 (some Dec Improved medicines management including polypharmacy Discussed at all annual practice prescribing visits
Bay%20GP%20Cluster%20Network%20Action%20Plan%202016%20-%2018.01.2017.docx